Evaluation of erythropoietin biosimilars Epotin™, Hemax® and Jimaixin™ by electrophoretic methods used for doping control analysis and specific N-glycan analysis revealed structural differences from original epoetin alfa drug Eprex®

Publication date: Available online 5 November 2020Source: Journal of Pharmaceutical and Biomedical AnalysisAuthor(s): Perrine Capdeville, Laurent Martin, Sophie Cholet, Annelaure Damont, Michel Audran, Magnus Ericsson, François Fenaille, Alexandre Marchand
Source: Journal of Pharmaceutical and Biomedical Analysis - Category: Drugs & Pharmacology Source Type: research